Search Orphan Drug Designations and Approvals
-
Generic Name: | Sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] |
---|---|
Date Designated: | 04/27/2021 |
Orphan Designation: | Treatment of Gastric Cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bold Therapeutics, Inc. 170 - 422 Richards Street, Vancouver, BC V6B 2Z4 Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-